Financials

  • Market Capitalization 3.49 B
  • Employee 601
  • Founded 2015
  • CEO -
  • Website www.arcusbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00DQD26W3
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.81
Relación precio/flujo de caja
9.87

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1587
DNLI
Denali Therapeutics Inc. - Common Stock
22.97 USD+1.41%-10.69%+3.84%+42.05%3.65 B USD
1597
GPCR
Structure Therapeutics Inc - American Depositary Shares
48.76 USD-3.62%-8.52%+14.17%+82.35%3.47 B USD
1608
ADPT
Adaptive Biotechnologies Corporation - Common Stock
22.56 USD+5.27%+13.65%+39.60%+30.71%3.61 B USD
1610
ARQT
Arcutis Biotherapeutics, Inc. - Common stock
27.81 USD+3.73%+0.69%+8.34%+78.84%3.48 B USD

Noticias